Al Ford serves as Chief Commercial Officer at KESTRA MEDICAL TECHNOLOGIES LTD, where he leads global sales, marketing, and business development efforts for the company’s innovative wearable cardioverter defibrillator and cardiac monitoring solutions. With more than 25 years in the medical device industry, Ford previously held senior leadership roles at Boston Scientific and ZOLL Medical, where he drove double-digit revenue growth through strategic market expansions and successful product launches targeting sudden cardiac arrest prevention. Throughout his career, Ford has been recognized for building high-performing commercial teams and forging key partnerships with healthcare systems and payers that improved patient access to life-saving technologies. His achievements include spearheading multiple FDA-cleared device commercializations and contributing to over $500 million in cumulative sales across cardiac rhythm management portfolios. In his current role at Kestra, Ford focuses on accelerating U.S. and international adoption of the company’s ASSURE wearable defibrillator system, emphasizing customer education, clinical evidence generation, and scalable go-to-market strategies that position Kestra as a leader in ambulatory cardiac care.